相关实验视频
Updated: Jun 15, 2025

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
Published on: January 25, 2016
在SLE中使用葡萄糖皮质类药物:一种临床方法
Daniel Martin-Iglesias1, Diana Paredes-Ruiz1, Guillermo Ruiz-Irastorza1,2
1Autoimmune Diseases Research Unit, Biobizkaia Health Research Institute, Department of Internal Medicine, Hospital Universitario Cruces, Spain.
葡萄糖皮质类药物 (GCs) 对全身性红斑狼 (SLE) 有效,但会造成损害. 量身定制GC剂量,使用甲基prednisolone脉冲,并与其他疗法结合,可以最大限度地减少伤害并实现缓解.
科学领域:
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 葡萄糖皮质类药物 (GCs) 是系统性红斑狼 (SLE) 的基石治疗.
- GC治疗与显著的累积损伤有关.
- 优化GC的使用对于平衡SLE管理中的有效性和安全性至关重要.
研究的目的:
- 审查SLE中GCs的药理基础,疗效和危害.
- 讨论SLE患者使用GC的当前指导方针和实践方法.
- 探索减少GC负担和实现退出的策略.
主要方法:
- 对SLE中GC疗效和毒性的药理学数据和临床证据的审查.
- 对SLE中GC管理的当前国际指导方针的分析.
- 讨论辅助疗法和GC戒断策略.
主要成果:
- 建议使用较低的GC初始剂量和快速逐渐减少的方案.
- 甲基prednisolone (MP) 脉冲可以减少口服GC的要求.
- 长期抗疟疾药物和早期免疫抑制剂改善了结果,并降低了GC毒性.
结论:
- 总体治疗需要仔细量身定制和逐渐缩小剂量,以尽量减少SLE的损害.
- 像MP脉冲和组合疗法这样的策略可以提高疗效,同时减少GC负担.
- 在稳定,长期缓解的患者中,GC退出是可行的.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

